P. Ponikowski, A. A. Voors, S. D. Anker, H. Bueno, J. Cleland et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC), 2016.

, Eur J Heart Fail, vol.18, pp.891-975, 2016.

F. Bursi, S. A. Weston, M. M. Redfield, S. J. Jacobsen, S. Pakhomov et al., Systolic and diastolic heart failure in the community, JAMA, vol.296, pp.2209-2216, 2006.

M. J. Lenzen, S. Op-reimer, W. J. Boersma, E. Vantrimpont, P. J. Follath et al., Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey, Eur Heart J, vol.25, pp.1214-1220, 2004.

K. S. Shah, H. Xu, R. A. Matsouaka, D. L. Bhatt, P. A. Heidenreich et al., Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes, J Am Coll Cardiol, vol.70, pp.2476-2486, 2017.

P. A. Mckee, W. P. Castelli, P. M. Mcnamara, and W. B. Kannel, The natural history of congestive heart failure: the Framingham study, N Engl J Med, vol.285, pp.1441-1446, 1971.

S. D. Solomon, A. R. Rizkala, J. Gong, W. Wang, I. S. Anand et al., Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: rationale and design of the PARAGON-HF trial, JACC Heart Fail, vol.5, pp.471-482, 2017.

L. H. Lund, D. E. Oger, E. Hage, C. Persson, H. Haugen-löfman et al., Ren Investigators. Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart

, Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fraction failure with preserved ejection fraction

, Eur J Heart Fail, vol.16, pp.992-1001, 2014.

E. Donal, L. H. Lund, C. Linde, M. Edner, S. Lafitte et al., Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction, Eur J Heart Fail, vol.11, pp.198-204, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00911681

T. S. Rector, Patient's self-assessment of their congestive heart failure: II. Content, reli-ability and validity of a new measure-The Minnesota Living with Heart Failure Questionnaire, Heart Fail, vol.3, 0198.

E. Donal, L. H. Lund, E. Oger, C. Hage, H. Persson et al., Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study, Arch Cardiovasc Dis, vol.107, pp.112-121, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01147020

R. S. Bhatia, J. V. Tu, D. S. Lee, P. C. Austin, J. Fang et al., Outcome of heart failure with preserved ejection fraction in a population-based study, N Engl J Med, vol.355, pp.260-269, 2006.

T. E. Owan, D. O. Hodge, R. M. Herges, S. J. Jacobsen, V. L. Roger et al., Trends in prevalence and outcome of heart failure with preserved ejection fraction, N Engl J Med, vol.355, pp.251-259, 2006.

H. Persson, D. E. Lund, L. H. Matan, D. Oger, E. Hage et al., Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines-a substudy in the Ka (Karolinska)
URL : https://hal.archives-ouvertes.fr/hal-01935766

, Int J Cardiol, vol.274, pp.202-207, 2018.

E. Donal, L. H. Lund, E. Oger, C. Hage, H. Persson et al., New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study, Eur J Heart Fail, vol.17, pp.680-688, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01162376

G. Savarese, N. Orsini, C. Hage, U. Dahlström, O. Vedin et al., Associations with and prognostic and discriminatory role of N-terminal pro-B-type natriuretic peptide in heart failure with preserved versus mid-range versus reduced ejection fraction, J Card Fail, vol.24, pp.365-374, 2018.